Hydroxyapatite (HAP) is the main inorganic component of human and animal bones. It can achieve chemical bonding with the body tissue at the interface. It has a certain solubility in the body, can release ions that are not harmful to the body, can participate in body metabolism, have a stimulating or inducing effect on bone hyperplasia, and promote defect tissue repair, showing biological activity. Hydroxyapatite has excellent biocompatibility and biological activity and can be used as a bone or tooth inducing factor. It has good remineralization, desensitization, and whitening effects on teeth in the field of oral health care.
The global hydroxyapatite market size was valued at USD 2.08 billion in 2019 and projected to reach USD 3.84 million by 2027, registering at a CAGR of 7.60% during the forecast period, 2020-2027. The major factors are the growing consumer awareness about bioactive ceramics and mounting healthcare expenditure across the globe. Additionally, the growing demand for dental and orthopedic implants and the mounting popularity of bioactive materials will trigger the global hydroxyapatite industry’s growth in future periods. The growing healthcare industry and easy availability of raw materials are strengthening market growth. The surge in need for knee and hip implants and the swelling number of plastic surgeries, especially nose and facelift, is anticipated to boost the hydroxyapatite market. The growing number of dental and orthopedic implants is anticipated to fuel hydroxyapatite’s demand globally in the coming years.
Moreover, the increase in demand for bone transplants and bone grafting materials will bolster the growth of global hydroxyapatite market share. The maturing population and the availability and reasonableness of orthopedic medications demonstrate the remarkable growth of the hydroxyapatite market in the coming years. The increasing incidences of bone and dental diseases, especially in developing countries, will propel the global hydroxyapatite market’s expansion in the forecast span. The swelling production of dental implants, hip, joints, and knee replacements is positively impacting the demand. Furthermore, the growing population of older people in developed countries fuels the demand for orthopedic implants, thereby propelling the hydroxyapatite market’s growth in the analysis timeframe. The increasing aged population, accident cases, and improper dental care are anticipated to promulgate the global hydroxyapatite industry’s expansion in the projected periods.
With the substantial increase in residents’ income, the society’s ability to pay for medical costs continues to strengthen, and the market demand for implanted medical will continue to grow. In recent years, the degree of aging has intensified in developing countries, and the elderly population has increased. The elderly population has a high proportion of various diseases, such as cardiovascular and cerebrovascular diseases, orthopedic diseases. 3D printing technology is developing rapidly and has been applied in clinical medicine to accurately replicate various implantable medical devices. With the improvement of residents’ consumption power, the improvement of the domestic medical insurance system, and the overall improvement of the clinician’s treatment level, the market share of medical implants products will further increase.
The improvement of living standards, the increase in public economic income, and increased awareness of oral health will propel a developing country’s dental, medical service industry is in a state of rapid growth. The growing number of geriatric people and increasing demand for retaining youth and beauty are vital factors for the growth of the global plastic surgery market. Also, technological advancements in surgeries and an increasing number of obese and overweight people have propelled the growth of the plastic surgery market in developing countries.
Based on the type, the global hydroxyapatite market segregated into nano-size, micro-size, and greater than micrometers. The nano-size segment is estimated to witness the highest growth over the analysis timeframe. It is mostly used in dental care products, orthopedics, plastic surgery, food, and pharmaceutical applications. It improved sinterability and enhanced densification; as a result, the fracture toughness and mechanical properties improve.
The micro-size will grow at a significant rate during the forecast period because it is used for the coating of metallic implants, and controlled delivery of therapeutic molecules.
Based on the application, the global hydroxyapatite market categorized into orthopedic (synthetic and natural source), dental care, plastic surgery, and others. The orthopedic segment held for the highest market share in 2019 and will witness to gain maximum market revenue by 2027. It is attributable to the hydroxyapatite is used for coating for implants, bone grafts, and bone fillers. Hydroxyapatite is an alternative to allogeneic and xenogeneic bone grafts for its bioactivity, resulting in the reduced healing time required.
The dental care segment is poised to witness significant growth over the forecast period. It is due to hydroxyapatite has excellent biocompatibility and biological activity and can be used as a bone or tooth inducing factor. It has good remineralization, desensitization, and whitening effects on teeth in the field of oral health care.
By geography, the global hydroxyapatite market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is projected to grow at the highest CAGR between 2020 and 2027. It is owing to the rising geriatric population globally, increasing awareness among masses about the advantages of dental bone grafting and bone grafting, and the swelling number of arthroplasty and dental implant surgeries performed in the region.
The Asia Pacific will capture a prominent share of the hydroxyapatite market by 2027. Due to the technological advancements and rise in disposables income in the middle-class.
Companies such as FLUIDINOVA, SofSera Corporation, Berkeley Advanced Biomaterials, Taihei Chemical Industrial Co. Ltd., SigmaGraft, CAM Bioceramics, Granulab (M) SDN BHD, Merz North America, Evonik Industries Ag, and Bionnovation are the key players in the global hydroxyapatite market.